1575550139
Medical Digest & Congress Report

Advertise on podcast: Medical Digest & Congress Report

This podcast has
795 episodes
Language
English
Explicit
No
Date created
2021/07/07
Latest episode
2026/11/10
Average duration
9 min.
Release period
1 days

Description

The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.

Unlock Medical Digest & Congress Report podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from Medical Digest & Congress Report podcast


Recent advances in the treatment of platinum-resistant ovarian cancer - report from ESMO 2026
2026/11/10
Professor Domenica Lorusso explores the latest therapeutic advances and emerging strategies for managing platinum-resistant ovarian cancer after the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:recent-advances-treatment-platinum-resistant-ovarian-cancer
KEYNOTE-C93: First-line pembrolizumab vs chemotherapy in dMMR advanced or recurrent endometrial carcinoma - report from ESMO 2026
2026/11/04
Doctor Brian M. Slomovitz presents Phase 3 KEYNOTE-C93/GOG-3064/ENGOT-en15 data evaluating first-line pembrolizumab monotherapy versus carboplatin plus paclitaxel in mismatch repair-deficient (dMMR) advanced or recurrent endometrial carcinoma at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:keynote-c93-first-line-pembrolizumab-vs-chemotherapy-dmmr-advanced-or-recurrent-endometrial-carcinoma
KEYNOTE-B49: Pembrolizumab plus chemotherapy in HR+/HER2− advanced breast cancer - report from ESMO 2026
2026/11/04
Doctor Hope S. Rugo presents results from the Phase 3 KEYNOTE-B49 study evaluating pembrolizumab versus placebo in combination with chemotherapy in patients with HR+/HER2− advanced breast cancer at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:keynote-b49-pembrolizumab-plus-chemotherapy-hrher2-advanced-breast-cancer
Advances in brain metastases management in breast cancer - report from ESMO 2026
2026/11/04
Professor Hope S. Rugo discusses key advances, targeted systemic options, and novel treatment strategies in managing brain metastases in patients with metastatic breast cancer at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:advances-brain-metastases-management-breast-cancer
DeLLphi-305: Tarlatamab plus durvalumab as 1L maintenance in extensive-stage SCLC - report from ESMO 2026
2026/11/04
Doctor Jacob Sands presents primary analysis data from the Phase 3 DeLLphi-305 trial, evaluating tarlatamab plus durvalumab versus durvalumab alone as first-line maintenance therapy for patients with extensive-stage small cell lung cancer (ES-SCLC) at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:available-research-guiding-selection-therapy-patients-chronic-lymphocytic-leukemia
Melanoma and skin tumours highlights from ESMO 2026
2026/11/04
Professor Karijn Suijkerbuijk summarizes the most important practice-changing trials, therapeutic updates, and clinical highlights in melanoma and other skin tumours presented at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:melanoma-and-skin-tumours-highlights-esmo-2026
Novelties in the treatment of colon cancer at ESMO 2026
2026/11/04
Professor Julien Taieb highlights key therapeutic novelties, emerging clinical trial results, and evolving treatment paradigms in colon cancer presented at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:novelties-treatment-colon-cancer-esmo-2026
A patient perspective on living with KRAS-mutated lung cancer - report from ESMO 2026
2026/11/04
Terri D. Conneran shares a powerful patient perspective on living with KRAS-mutated lung cancer and advancing the frontiers of patient-centric care at the ESMO Congress 2026. For more information and resources, visit the KRAS Kickers website. Video: https://medicaldigest.org/scientific-contents/interview:patient-perspective-living-kras-mutated-lung-cancer
INTerpath-001: Adjuvant mRNA neoantigen therapy intismeran plus pembrolizumab in resected stage IIB–IV melanoma - report from ESMO 2026
2026/11/04
Professor Georgina V. Long presents the Phase III INTerpath-001 trial results evaluating the mRNA-based individualized neoantigen therapy intismeran autogene in combination with pembrolizumab versus pembrolizumab alone as adjuvant treatment for patients with resected stage IIB–IV melanoma at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:interpath-001-adjuvant-mrna-neoantigen-therapy-intismeran-plus-pembrolizumab-resected-stage-iibiv-melanoma
Head and neck cancer highlights from ESMO 2026
2026/11/03
Professor Amanda Psyrri summarizes the most important practice-changing trial results, emerging biomarker data, and therapeutic advances in head and neck cancer presented at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:head-and-neck-cancer-highlights-esmo-2026
Key clinical updates in gastroesophageal cancer: HERIZON-GEA-01 and CLARITY-Gastric 01 - report from ESMO 2026
2026/11/03
Professor Kohei Shitara discusses key findings from two pivotal late-breaking trials in gastroesophageal cancer presented at the ESMO Congress 2026: the HERIZON-GEA-01 study and the CLARITY-Gastric 01 trial. Video: https://medicaldigest.org/scientific-contents/interview:key-clinical-updates-gastroesophageal-cancer-herizon-gea-01-and-clarity-gastric-01
Advancing clinical practice and patient care in gastroesophageal cancer - report from ESMO 2026
2026/11/03
Doctor Kohei Shitara highlights key advances in clinical practice, evolving therapeutic strategies, and patient care management in gastroesophageal cancer at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:advancing-clinical-practice-and-patient-care-gastroesophageal-cancer
Breast cancer highlights from ESMO 2026
2026/11/03
Professor Alessandra Gennari summarizes the key practice-changing trials, biomarker advances, and clinical highlights in breast cancer presented at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:breast-cancer-highlights-esmo-2026
KRASCENDO-1: Divarasib versus sotorasib or adagrasib in KRAS G12C-mutated NSCLC - report from ESMO 2026
2026/11/03
Professor Ferdinandos Skoulidis presents the landmark Phase III KRASCENDO-1 study results evaluating the efficacy and safety of divarasib versus standard-of-care sotorasib or adagrasib in previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:krascendo-1-divarasib-versus-sotorasib-or-adagrasib-kras-g12c-mutated-nsclc
Reshaping adjuvant and perioperative strategies in CSCC - report from ESMO 2026
2026/11/03
Doctor Vishal A. Patel discusses reshaping adjuvant and perioperative strategies in cutaneous squamous cell carcinoma (CSCC), highlighting the integration of surgery, radiation, and systemic therapies through multidisciplinary decision-making at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:reshaping-adjuvant-and-perioperative-strategies-cscc

Podcast reviews

Read Medical Digest & Congress Report podcast reviews


0 out of 5
0 reviews

Podcast sponsorship advertising

Start advertising on Medical Digest & Congress Report relevant audience podcasts


What do you want to promote?